Skip to main content
GILD
NASDAQ Life Sciences

Gilead Finalizes $3.15B Tubulis Acquisition, Adds Key Oncology ADC Assets

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$129.8
Mkt Cap
$162.261B
52W Low
$104.46
52W High
$157.29
52W Position info
24% above low
Off High info
17% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

GILD sits 24% above its 52-week low of $104.46.

Summary

Gilead Sciences has completed its acquisition of Tubulis for $3.15 billion upfront, with potential milestone payments up to $1.85 billion. This strategic move significantly expands Gilead's oncology portfolio by adding next-generation antibody-drug conjugates (ADCs), including TUB-040 for platinum-resistant ovarian cancer and TUB-030 for solid tumors. The acquisition follows Gilead's recent aggressive M&A activity, including the Arcellx deal, and a $3 billion senior notes offering to fund these expansions. While Q1 earnings already factored in substantial IPR&D charges from recent acquisitions, the completion of this specific deal confirms the deployment of significant capital into a key growth area.

At the time of this announcement, GILD was trading at $129.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $162.3B. The 52-week trading range was $104.46 to $157.29. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

GILD - Latest Insights

GILD
Nov 06, 2026, 12:16 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $167.82
Real-time Price: $167.58 info
Change: -$0.235 (-0.14%) info
Market Cap: $206.43B info
GILD
Nov 05, 2026, 10:35 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $174.57
Real-time Price: $167.58 info
Change: -$6.98 (-4%) info
Market Cap: $206.43B info
GILD
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $165.88
Real-time Price: $167.58 info
Change: +$1.70 (+1%) info
Market Cap: $206.43B info
GILD
Oct 29, 2026, 4:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $164.00
Real-time Price: $167.58 info
Change: +$3.58 (+2%) info
Market Cap: $206.43B info
GILD
Oct 22, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $157.19
Real-time Price: $167.58 info
Change: +$10.39 (+7%) info
Market Cap: $206.43B info